<bill session="115" type="h" number="1162" updated="2017-08-10T13:23:30Z">
  <state datetime="2017-05-23T15:35:26-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2017-05-23T15:35:26-04:00"/>
  </status>
  <introduced datetime="2017-02-16"/>
  <titles>
    <title type="short" as="introduced">No Hero Left Untreated Act</title>
    <title type="short" as="introduced">No Hero Left Untreated Act</title>
    <title type="short" as="reported to house">No Hero Left Untreated Act</title>
    <title type="short" as="passed house">No Hero Left Untreated Act</title>
    <title type="short" as="passed house">No Hero Left Untreated Act</title>
    <title type="official" as="introduced">To direct the Secretary of Veterans Affairs to carry out a pilot program to provide access to magnetic EEG/EKG-guided resonance therapy to veterans.</title>
    <title type="display">No Hero Left Untreated Act</title>
  </titles>
  <sponsor bioguide_id="K000387"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2017-02-16"/>
    <cosponsor bioguide_id="B001299" joined="2017-02-16"/>
    <cosponsor bioguide_id="B001301" joined="2017-02-16"/>
    <cosponsor bioguide_id="B001289" joined="2017-02-16"/>
    <cosponsor bioguide_id="C000059" joined="2017-02-16"/>
    <cosponsor bioguide_id="C001068" joined="2017-02-16"/>
    <cosponsor bioguide_id="C001053" joined="2017-02-16"/>
    <cosponsor bioguide_id="C001093" joined="2017-04-06"/>
    <cosponsor bioguide_id="C001105" joined="2017-02-16"/>
    <cosponsor bioguide_id="C001094" joined="2017-02-16"/>
    <cosponsor bioguide_id="C001106" joined="2017-05-18"/>
    <cosponsor bioguide_id="D000598" joined="2017-02-16"/>
    <cosponsor bioguide_id="D000612" joined="2017-02-16"/>
    <cosponsor bioguide_id="F000466" joined="2017-02-16"/>
    <cosponsor bioguide_id="F000448" joined="2017-02-16"/>
    <cosponsor bioguide_id="G000571" joined="2017-02-16"/>
    <cosponsor bioguide_id="G000559" joined="2017-02-16"/>
    <cosponsor bioguide_id="G000582" joined="2017-05-18"/>
    <cosponsor bioguide_id="H001053" joined="2017-02-16"/>
    <cosponsor bioguide_id="H001064" joined="2017-02-16"/>
    <cosponsor bioguide_id="J000290" joined="2017-04-06"/>
    <cosponsor bioguide_id="J000255" joined="2017-02-16"/>
    <cosponsor bioguide_id="J000295" joined="2017-02-16"/>
    <cosponsor bioguide_id="K000375" joined="2017-02-16"/>
    <cosponsor bioguide_id="K000210" joined="2017-02-16"/>
    <cosponsor bioguide_id="K000382" joined="2017-02-16"/>
    <cosponsor bioguide_id="L000578" joined="2017-02-16"/>
    <cosponsor bioguide_id="L000559" joined="2017-02-16"/>
    <cosponsor bioguide_id="L000582" joined="2017-02-16"/>
    <cosponsor bioguide_id="L000554" joined="2017-02-16"/>
    <cosponsor bioguide_id="M001199" joined="2017-04-06"/>
    <cosponsor bioguide_id="M001165" joined="2017-02-16"/>
    <cosponsor bioguide_id="M001180" joined="2017-02-16"/>
    <cosponsor bioguide_id="M001196" joined="2017-02-16"/>
    <cosponsor bioguide_id="O000170" joined="2017-02-16"/>
    <cosponsor bioguide_id="P000605" joined="2017-02-16"/>
    <cosponsor bioguide_id="P000608" joined="2017-04-06"/>
    <cosponsor bioguide_id="P000597" joined="2017-02-16"/>
    <cosponsor bioguide_id="P000592" joined="2017-02-16"/>
    <cosponsor bioguide_id="P000523" joined="2017-02-16"/>
    <cosponsor bioguide_id="Q000023" joined="2017-02-16"/>
    <cosponsor bioguide_id="R000600" joined="2017-02-16"/>
    <cosponsor bioguide_id="R000591" joined="2017-02-16"/>
    <cosponsor bioguide_id="R000583" joined="2017-02-16"/>
    <cosponsor bioguide_id="R000604" joined="2017-02-16"/>
    <cosponsor bioguide_id="S001189" joined="2017-02-16"/>
    <cosponsor bioguide_id="S001170" joined="2017-02-16"/>
    <cosponsor bioguide_id="S000480" joined="2017-02-16"/>
    <cosponsor bioguide_id="S001200" joined="2017-02-16"/>
    <cosponsor bioguide_id="S001196" joined="2017-02-16"/>
    <cosponsor bioguide_id="S001192" joined="2017-02-16"/>
    <cosponsor bioguide_id="T000460" joined="2017-02-16"/>
    <cosponsor bioguide_id="V000129" joined="2017-02-16"/>
    <cosponsor bioguide_id="W000813" joined="2017-02-16"/>
    <cosponsor bioguide_id="W000820" joined="2017-02-16"/>
    <cosponsor bioguide_id="W000804" joined="2017-02-16"/>
  </cosponsors>
  <actions>
    <action datetime="2017-02-16">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-02-16" state="REFERRED">
      <text>Referred to the House Committee on Veterans' Affairs.</text>
    </action>
    <action datetime="2017-03-03">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2017-03-29">
      <text>Subcommittee Hearings Held.</text>
    </action>
    <action datetime="2017-04-06">
      <text>Forwarded by Subcommittee to Full Committee by Voice Vote .</text>
    </action>
    <action datetime="2017-05-17">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2017-05-17" state="REPORTED">
      <text>Ordered to be Reported by Voice Vote.</text>
    </calendar>
    <action datetime="2017-05-23">
      <text>Reported by the Committee on Veterans' Affairs. H. Rept. 115-147.</text>
    </action>
    <calendar datetime="2017-05-23" calendar="Union" number="95">
      <text>Placed on the Union Calendar, Calendar No. 95.</text>
    </calendar>
    <action datetime="2017-05-23T15:27:34-04:00">
      <text>Mr. Roe (TN) moved to suspend the rules and pass the bill.</text>
    </action>
    <action datetime="2017-05-23T15:27:42-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H4469-4473" label="consideration"/>
    </action>
    <action datetime="2017-05-23T15:27:43-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 1162.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2017-05-23T15:35:26-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill Agreed to by voice vote.</text>
      <reference ref="CR H4470" label="text"/>
    </vote>
    <action datetime="2017-05-23T15:35:27-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2017-05-24">
      <text>Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSVA" name="Senate Veterans' Affairs" activity="Referral"/>
    <committee subcommittee="" code="HSVR" name="House Veterans' Affairs" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="Health" code="HSVR03" name="House Veterans' Affairs" activity="Reporting, Hearings, Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="115" relation="identical" number="514"/>
  </relatedbills>
  <subjects>
    <term name="Armed forces and national security"/>
    <term name="Crime victims"/>
    <term name="Department of Veterans Affairs"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Health facilities and institutions"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Neurological disorders"/>
    <term name="Sex offenses"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2017-05-23T13:53:08Z" status="Passed House without amendment">(This measure has not been amended since it was introduced. The summary of that version is repeated here.)

No Hero Left Untreated Act

This bill requires the Department of Veterans Affairs (VA) to carry out a one-year pilot program to provide access to magnetic EEG/EKG-guided resonance therapy to treat veterans suffering from post-traumatic stress disorder, traumatic brain injury, military sexual trauma, chronic pain, or opiate addiction.

The VA shall: (1) carry out the program at up to two VA facilities, and (2) provide access to such therapy to more than 50 veterans.</summary>
  <committee-reports>
    <report>H. Rept. 115-147</report>
  </committee-reports>
</bill>
